about
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope ProteinCD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human HepatocytesMutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggsPathogenic potential of interferon αβ in acute influenza infectionType I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epitheliaA serpin shapes the extracellular environment to prevent influenza A virus maturationHepatitis C virus e2 protein ectodomain is essential for assembly of infectious virionsProgressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines.TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection.The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development.The aryl hydrocarbon receptor controls cyclin O to promote epithelial multiciliogenesis.Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells.Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line.IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.Immortalization of multipotent growth-factor dependent hemopoietic progenitors from mice transgenic for GATA-1 driven SV40 tsA58 gene.Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cellsImmortalization of neuro-endocrine cells from adrenal tumors arising in SV40 T-transgenic miceInfluenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protectionType I and III interferons disrupt lung epithelial repair during recovery from viral infection
P50
Q27485143-F0E7526D-C389-40CD-8FB1-7F5A9360F1FBQ27486789-698EB70C-0FC2-4F8E-BF91-3C066F59E306Q30391377-2AD6CBD1-69F6-45C6-86A9-25F922F46FBEQ33663298-E6E67D7D-AC61-4922-8F2F-9AA8D7C71AD5Q35053045-20A7F6E2-B7F4-43E7-B96A-2D2FB643293AQ35083702-10B30102-0C38-4B38-A1F3-EE16B3F8A141Q35212817-BC57172A-948A-4625-8599-842DC6878626Q35891531-FF9018C7-FD82-498C-9855-E8D01F789753Q36078577-958596CB-43A2-4B61-821E-6FB42AA00A06Q37627731-D544B33D-E307-4A1D-8133-AFDBD8C6E0F5Q39460723-195836BE-232E-498B-9677-5EE303D8DF01Q39610828-2C488F03-8BED-4586-957E-58773D7F2A3AQ40208239-826F6085-C4A0-4DB9-A705-0AC3699C3C58Q40577440-2B55003E-2E02-47EC-BBF5-0F47D683CBC8Q40793361-E77F500B-CBF8-4949-8171-61228036FD4CQ42993633-FF3E0E21-0EFF-4AC7-829D-A1700E476A01Q56987962-D6C6CA7D-E4E4-4CB6-80B3-6AE7CF3569D7Q73511414-4CEA5BAE-E69B-487A-B9B4-B33ED10D61E0Q92611347-1475905F-0C75-4EA9-A701-CDD28CA14353Q96302254-8BC6D0D0-9765-4E7E-B470-DBDBF202959B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefania Crotta
@ast
Stefania Crotta
@en
Stefania Crotta
@es
Stefania Crotta
@nl
type
label
Stefania Crotta
@ast
Stefania Crotta
@en
Stefania Crotta
@es
Stefania Crotta
@nl
prefLabel
Stefania Crotta
@ast
Stefania Crotta
@en
Stefania Crotta
@es
Stefania Crotta
@nl
P106
P21
P31
P496
0000-0003-4676-8616